glp 1 and colonoscopy prep GLP-1s May Lead to an Increased Risk of Post-Endoscopy Aspiration Pneumonia Impact of GLP-1 Receptor Agonists

The Clinical Evidence Animal Studies (Compelling Foundation) Multiple animal studies have shown dramatic results: Rat tendon repair (2015 study): BPC-157 treated group: 87% functional recovery by day 14 Control group: 42% functional recovery by day 14 Treated tendons showed superior collagen organization and strength Rat ACL studies: BPC-157 accelerated cruciate ligament healing Improved biomechanical properties of healed tissue Enhanced recovery of motor function Systemic benefits: Improved gastric ulcer healing (origin research) Accelerated bone fracture healing Enhanced wound healing Human Clinical Data (Emerging) While human long-term trials are still limited, preliminary human studies show: Chronic tendinopathy cases: Improvements in pain and function Better ultrasound imaging of tendon structure Return to activity timelines shortened by 30-50% in pilot studies Post-surgical recovery: Athletes returning to training faster Reduced post-operative pain Better functional outcomes in ACL reconstructions (preliminary data) Safety profile: No serious adverse events in human trials to date Well-tolerated across multiple routes of administration No apparent systemic toxicity Important caveat : Human clinical research on BPC-157 is still in early stages

It also plays a vital role in supporting the immune system and liver function

L- Carnitine

From which pharmacy

[3] Two research-context points follow from this